How to diagnose advanced gastric cancer

Gastric cancer is diagnosed based on the following auxiliary examinations: Gastroscopy and biopsy: clarify the location, size and shape of the lesion, and do more biopsy points to understand the tissue classification, degree of differentiation, growth pattern, etc. The main basis for clinical diagnosis: no symptoms and signs in the early stage, or upper abdominal pain, full stomach discomfort, loss of appetite or aggravation of the original gastric ulcer symptoms, persistent abdominal pain or loss of rhythm, according to the ulcer treatment symptoms are not relieved, vomiting blood, black stools may occur. For gastric malignant tumors, it is recommended that you conduct further examinations before making a judgment.

How much does it cost to cure stomach cancer?

Gastric cancer is also a common malignant tumor in the digestive tract. For early gastric cancer, it can usually be completely cured by surgery. Generally speaking, most patients find that it is in the middle and late stages. If radiotherapy and chemotherapy are required after surgery, the general cost is 70,000 or 80,000. The cost of surgery for gastric tumors is generally 50,000, and most of them are between 10,000 and 30,000. It is not ruled out that some hospitals will charge higher fees due to the use of equipment, but to cure gastric tumors, combined with comprehensive treatment methods such as chemotherapy and radiotherapy, the cost will be much higher than 100,000. If gastric cancer patients are found early, they can be cured from a clinical point of view, that is, they can be cured.

What are the targeted drugs for gastric cancer?

Apatinib, trastuzumab, Herceptin and other commonly used targeted drugs for gastric cancer. These drugs are mainly used to treat metastatic gastric cancer and can effectively control the continued development of the disease. They can also effectively improve the patient's quality of life and prolong the patient's survival. Currently, the commonly used targeted drugs are mainly trastuzumab and apatinib. If the patient has a good effect on a certain targeted drug and the patient can tolerate the side effects of the targeted drug, the targeted drug should be taken all the time without stopping the drug.